▶주메뉴 바로가기

▶본문 바로가기

검색폼

THE INVESTOR

Stocks & Bonds

[STOCK WATCH] Ilyang Pharmaceutical falls 2.06%,

  • PUBLISHED :September 14, 2017 - 11:14
  • UPDATED :September 14, 2017 - 11:14
  • 폰트작게
  • 폰트크게
  • facebook
  • twitter
  • sms
  • print
[THE INVESTOR] As of Sept. 14 10:25 A.M., Ilyang Pharmaceutical declined 2.06%, compared with yesterday, to 33,350 won. It had declined 3.47% through the past month. Standard deviation, which indicates variableness, records 1.5% over the same period of time over one month.

Compared with its close competitors within the same industry, KOSPI, since the monthly volatility of Ilyang Pharmaceutical was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.3%. 

The return-on-risk is below the industrial mean, 1.2, and thus the industrial comparison performance was not so good.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
  • facebook
  • twitter
  • sms
  • print

EDITOR'S PICKS